Banner - NPPA Connect

NP/PA Connect
News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

|Videos|August 26, 2021

Combination Therapies with Monica Bonakdar, MD

Author(s)Linda Stocum, Associate Editor

In this video interview, Monica Bonakdar, MD, shares her thoughts on combination therapies, how COVID-19 affected her practice, and more.

Monica Bonakdar, MD, cosmetic dermatologist, Newport Beach, California spoke about how she utilizes combination therapies in her practice and their effectiveness for patient treatment. She also speaks on the challenges of COVID-19, and how practice was made stronger because of it.

Want to hear what else she has to say? Watch the video below.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Social Media Mythbusters: The Summer Skin Care "Shutdown"

ByMarie Bosslett, Assistant Editor

July 18th 2026

What's Next for Fractional Laser Therapy After the Epigenetic Findings?

ByKonika Patel Schallen, MD,Shannon Heaning, Content Associate

July 17th 2026

Optimizing Patient Comfort and Recovery in Thread Lifting via Novel VectorLift Method

ByMarie Bosslett, Assistant Editor

July 16th 2026

DNA Methylation Changes Tied to Laser Skin Resurfacing

ByKonika Patel Schallen, MD,Shannon Heaning, Content Associate

July 15th 2026

Study Suggests Non-Ablative Fractional Laser Reverses Epigenetic Signatures of Skin Aging

ByKonika Patel Schallen, MD,Shannon Heaning, Content Associate

July 13th 2026

Latest CME

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

Social Media Mythbusters: The Summer Skin Care "Shutdown"

Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites

ED Treatment Gaps Persist for Pediatric Atopic Dermatitis

Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe AD

Breakout Bulletin: July 13-July 17